Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01842334 · ClinicalTrials.gov registry record · Phase 1
D-cycloserine (DCS) Pretreatment + CBT + Nicotine Replacement Therapy for Smoking Cessation (DCS)
A Phase 1 study, sponsored by Mclean Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT01842334 is a Phase 1 study that was terminated before completion, run by Mclean Hospital. The registered enrollment target is 22 participants.
The verdict
NCT01842334, a Phase 1 study, was terminated before completion, sponsored by Mclean Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
1. Compare the relative efficacy of ten weeks of once weekly 250 mg D-cycloserine (DCS) vs. placebo (both in conjunction with cognitive behavioral therapy (CBT) and nicotine replacement therapy (NRT) on reducing cigarette smoking in treatment-seeking nicotine-dependent outpatients. 2. Compare the relative efficacy of ten weeks of once weekly 250 mg DCS vs. placebo on the process of extinction and the memory encoding process.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- DRUG Nicotine Replacement Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01842334
The ClinicalTrials.gov registry entry for NCT01842334 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01842334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01842334 about?
NCT01842334 is a clinical study titled "D-cycloserine (DCS) Pretreatment + CBT + Nicotine Replacement Therapy for Smoking Cessation (DCS)". 1. Compare the relative efficacy of ten weeks of once weekly 250 mg D-cycloserine (DCS) vs. placebo (both in conjunction with cognitive behavioral therapy (CBT) and nicotine replacement therapy (NRT) on reducing cigarette smoking in treatment-seeking nicotine-dependent outpatients. 2. Compare the re...
What is the current status of trial NCT01842334?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2013-04. Estimated completion is 2017-08.
What interventions are being tested in trial NCT01842334?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Nicotine Replacement Therapy (DRUG).
Who is sponsoring clinical trial NCT01842334?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.